Low- versus high-dose rituximab for rheumatoid arthritis: a systematic review and meta-analysis.
about
Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritisRituximab for Rheumatoid Arthritis.Rituximab associated late-onset neutropenia-a rheumatology case series and review of the literature.Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaborationUpdated systematic review and meta-analysis of randomized controlled trials comparing low- versus high-dose rituximab for rheumatoid arthritis.Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial.Rituximab for the treatment of rheumatoid arthritis: an update.An update on the management of hepatitis C virus-related arthritis.Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis.Targeting B cells in relapsing-remitting multiple sclerosis: from pathophysiology to optimal clinical management.bDMARD Dose Reduction in Rheumatoid Arthritis: A Narrative Review with Systematic Literature Search.Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study.Remission of Refractory Membranous Nephropathy by Low-dose Rituximab: A Case Report.Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial.Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial.Cost-effectiveness analysis of two rituximab retreatment regimens for longstanding rheumatoid arthritis.Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases. Results of a lower dosage and shorter interval regimen.Is an extra dose of rituximab an efficacious and safe alternative to improve outcomes in rheumatoid arthritis? Comment on the article by Vital et al.Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.Choosing the right rituximab dose for the right patient: comment on the article by Bredemeier et al.Response to Dr Bredemeier's letter.Kinetic changes of regulatory B10 cells in collagen-induced arthritis could be regulated by cytokines IFN-γ and TGF-β1.Monitoring B-cell repopulation after depletion therapy in neurologic patients.Q56958599
P2860
Q26852081-D3D9FEC9-EF97-45C1-9BFF-5EF3690200B4Q28080246-F30E7A32-7D20-444E-85E4-914426754A01Q30250242-B75E6524-E695-417F-926D-C07290FE7B69Q31046441-B114BD4F-4FE7-4397-BF51-B8D52767C7F7Q35662575-1BE14917-8B40-4BF6-8343-E2F1D1A5F08BQ35809549-0DCC327E-0F5E-4217-83D3-9179883071ABQ37444678-2B7D709E-617B-447C-BB4C-866C8DF589F8Q38242116-BD91A101-AA18-4309-AA48-80E5D62A8BD4Q38540353-A43DF0BF-05C8-4576-B332-E92A914B1A3BQ38690022-621B97C9-FBFA-4541-931A-66C192CED311Q38751251-3519451E-68D9-454F-B0C2-7F521762319DQ39692977-19D1AC34-FC92-41B4-92C8-385DEC5F08B4Q39830050-7E9FFF0E-B610-4A51-A1D9-9892B712BD2BQ40127724-F4262444-3C01-47D7-AA5D-42E73E10159BQ41571651-52DDA605-FF9B-4819-A152-3FC68790F576Q41593204-FDA37BA8-67E4-4EE3-9FA2-684298111066Q42639790-010B77F3-9DAC-4A4D-A406-6DD2AB30CE60Q45765360-9BFF2583-6FEE-4A22-9CA8-5D51CDDF060AQ50014741-8E31D088-539B-4868-9F7D-121903AF9039Q52839527-9DA77AD7-BE83-4A6F-8D7B-0CAFE2958FBFQ52840072-4CA96462-7509-446B-B841-12670932FB95Q53452331-EAB19E1A-0AE8-4D2F-B0E2-E3A48801D0E2Q55283551-9F94BD9A-A8BE-434A-8F77-47CCC0E35683Q56958599-D80F2534-FFE9-4EE7-9C32-FAF1D4281E88
P2860
Low- versus high-dose rituximab for rheumatoid arthritis: a systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Low- versus high-dose rituxima ...... atic review and meta-analysis.
@ast
Low- versus high-dose rituxima ...... atic review and meta-analysis.
@en
Low- versus high-dose rituxima ...... atic review and meta-analysis.
@nl
type
label
Low- versus high-dose rituxima ...... atic review and meta-analysis.
@ast
Low- versus high-dose rituxima ...... atic review and meta-analysis.
@en
Low- versus high-dose rituxima ...... atic review and meta-analysis.
@nl
prefLabel
Low- versus high-dose rituxima ...... atic review and meta-analysis.
@ast
Low- versus high-dose rituxima ...... atic review and meta-analysis.
@en
Low- versus high-dose rituxima ...... atic review and meta-analysis.
@nl
P2860
P356
P1476
Low- versus high-dose rituxima ...... atic review and meta-analysis.
@en
P2093
Cláudia M Rocha
Fernando K de Oliveira
P2860
P304
P356
10.1002/ACR.22116
P577
2014-02-01T00:00:00Z